Rxcelerate
Outsourced drug discovery and preclinical services for biotech and life science companies, spanning small molecules and biologics
Highlights
- New on EvolcAdded 2026-10-27
About Rxcelerate
RxCelerate provides outsourced drug discovery and development services for small molecules and biologics. Its offering covers programme design and management, in vitro and in vivo assays, chemistry, in silico design, antibody discovery, DMPK studies and proteomics. Proprietary platforms include RxPlorer, a metastate discovery platform, Rxnfinity for in silico screening, the Galaxy antibody discovery platform and the ProQuant proteomics platform.
Its customers are biotechnology and life science companies, including venture-backed companies. The company states that its business model is driven by success rather than volume of work, and reports 77% repeat business.
RxCelerate was founded in 2012 and is headquartered in Cambridge, UK. It is part of the RxCelerate Group, which includes the sister companies RxBiologics and The Cambridge Partnership. The website describes a team of over a hundred experts and cites 27+ clinical candidates and 16 drugs in the clinic.
Product: Outsourced drug discovery and development services, including in silico design, antibody discovery, assays, chemistry, DMPK and proteomics, with the RxPlorer, Rxnfinity, Galaxy and ProQuant platforms.
Jobs at Rxcelerate
Leadership
- Jill Reckless · Co-founder & CEOSource: company website
- Nick Tait · CFOSource: company website
More biotech & pharma companies
Saspiphi
Engineered bacteriophage therapeutics targeting harmful bacteria for antimicrobial treatment developmentYoung companyNew on EvolcScancell
Clinical-stage immunotherapy developer for difficult-to-treat cancers, using Immunobody and Moditope platformsNew on EvolcScripta Therapeutics
Drug discovery platform using transcription factor mapping and AI models to find neurodegenerative disease therapiesYoung companyNew on EvolcSENTINAL4D
AI models and imaging data tools for biotech and pharmaceutical R&D teams studying cell morphology and drug responsesYoung companyNew on EvolcSequoia Genetics
Human genetics research and analysis for pharma, biotech, investors, and academic institutions developing medicinesYoung companyNew on EvolcSeren Plus
Wholesale supplier of prescription medicines and aesthetic products to pharmacies and clinics across the UKNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Azure
- Cloudflare
- CookieYes
- Google Analytics 4
- Mailchimp
- WordPress
- jQuery